Clinical Trial Update: Safety and Efficacy Study of EXC 001 to Improve the Appearance of Scars From Prior Breast Surgery [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating EXC 001 for improving appearance of scars after breast surgery; study completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertrophic Scar
• Scarring After Breast Surgery

Drugs mentioned

• EXC 001

Snippet

Sponsor: Pfizer | Conditions: Reduction in Hypertrophic Skin Scarring | Phase 2 | Status: COMPLETED | Results posted: 2021-09-09